ITCI: Intra-Cellular Therapies Inc. Stocks News on November 21, 2024

ITCI

MT Newswires

2 days ago

UBS Raises Price Target on Intra-Cellular Therapies to $87 From $79, Maintains Neutral Rating

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

ITCI

GlobeNewswire

2 days ago

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

ITCI

MT Newswires

6 days ago

Intra-Cellular Therapies Insider Sold Shares Worth $3,692,100, According to a Recent SEC Filing

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

ITCI

GlobeNewswire

14 days ago

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

Intra-Cellular bolsters Caplyta data with another Phase III win

ITCI

Pharmaceutical Technology

15 days ago

Intra-Cellular bolsters Caplyta data with another Phase III win

ITCI

Clinical Trials Arena

15 days ago

Intra-Cellular bolsters Caplyta data with another Phase III win

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

ITCI

GlobeNewswire

16 days ago

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

ITCI

Simply Wall St.

19 days ago

Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results

Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

ITCI

Simply Wall St.

20 days ago

Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

ITCI

GuruFocus.com

21 days ago

Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...

ITCI

Zacks

22 days ago

ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales

ITCI

Zacks

22 days ago

Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates

ITCI

MT Newswires

22 days ago

Intra-Cellular Therapies Posts Unchanged Q3 Net Loss, Revenue Rises

ITCI

Associated Press Finance

22 days ago

Intra-Cellular: Q3 Earnings Snapshot

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

ITCI

GlobeNewswire

22 days ago

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

ITCI

GuruFocus.com

23 days ago

What To Expect From Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings

ITCI

Zacks

a month ago

Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Should You Buy?

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

ITCI

GlobeNewswire

a month ago

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

ITCI

Insider Monkey

a month ago

Intra-Cellular Therapies, Inc. (ITCI): Among the Most Promising Mid-Cap Stocks According to Hedge Funds

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

ITCI

Zacks

a month ago

Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

ITCI

MT Newswires

a month ago

Morgan Stanley Raises Price Target on Intra-Cellular Therapies to $95 From $92, Keeps Overweight Rating

JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc

ITCI

GuruFocus.com

a month ago

JPMorgan Chase & Co's Strategic Acquisition of Shares in Intra-Cellular Therapies Inc

ITCI

MT Newswires

2 months ago

RBC Lifts Price Target on Intra-Cellular Therapies to $108 From $106, Keeps Outperform Rating

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

ITCI

GlobeNewswire

2 months ago

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

ITCI

Simply Wall St.

2 months ago

Intra-Cellular Therapies (NASDAQ:ITCI) delivers shareholders fantastic 54% CAGR over 5 years, surging 3.9% in the last week alone

ITCI

Zacks

2 months ago

Why Is Intra-Cellular (ITCI) Down 2.7% Since Last Earnings Report?

ITCI

MT Newswires

2 months ago

Piper Sandler Upgrades Intra-Cellular Therapies to Overweight From Neutral, $92 Price Target

ITCI

Insider Monkey

3 months ago

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Mid-Cap Healthcare Stocks To Buy Now

ITCI

MT Newswires

3 months ago

Intra-Cellular Therapies Insider Sold Shares Worth $5,089,236, According to a Recent SEC Filing

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

ITCI

GlobeNewswire

3 months ago

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

ITCI

MT Newswires

3 months ago

Intra-Cellular Therapies Insider Sold Shares Worth $9,086,738, According to a Recent SEC Filing

ITCI

Simply Wall St.

3 months ago

Here's Why We're Not At All Concerned With Intra-Cellular Therapies' (NASDAQ:ITCI) Cash Burn Situation

Biotech Stock Pulls Back After Earnings Report; Profits On The Horizon

ITCI

Investor's Business Daily

3 months ago

Biotech Stock Pulls Back After Earnings Report; Profits On The Horizon

ITCI

MT Newswires

3 months ago

UBS Adjusts Price Target on Intra-Cellular Therapies to $79 From $83, Maintains Neutral Rating

ITCI

Zacks

3 months ago

Intra-Cellular (ITCI) Q2 Loss Narrower Than Expected, Sales Beat

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

ITCI

GlobeNewswire

3 months ago

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

ITCI

MT Newswires

3 months ago

RBC Trims Price Target on Intra-Cellular Therapies to $106 From $107, Keeps Outperform Rating

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'

ITCI

Investor's Business Daily

3 months ago

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'

ITCI

MT Newswires

3 months ago

Intra-Cellular Therapies Appoints Sanjeev Narula CFO

ITCI

Zacks

3 months ago

Intra-Cellular Therapies (ITCI) Reports Q2 Loss, Tops Revenue Estimates

ITCI

MT Newswires

3 months ago

Intra-Cellular Therapies Q2 Net Loss Narrows, Revenue Rises

ITCI

Associated Press Finance

3 months ago

Intra-Cellular: Q2 Earnings Snapshot

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

ITCI

GlobeNewswire

3 months ago

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

ITCI

GlobeNewswire

3 months ago

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

ITCI

Zacks

4 months ago

Arcus Biosciences, Inc. (RCUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

ITCI

Zacks

4 months ago

Intra-Cellular Therapies (ITCI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

ITCI

GlobeNewswire

4 months ago

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

ITCI

MT Newswires

4 months ago

Needham Adjusts Intra-Cellular Therapies Price Target to $100 From $94, Maintains Buy Rating

ITCI

Simply Wall St.

4 months ago

Analysts Expect Breakeven For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Before Long

ITCI

Zacks

4 months ago

Wall Street Analysts See a 30.14% Upside in Intra-Cellular (ITCI): Can the Stock Really Move This High?

ITCI

MT Newswires

4 months ago

RBC Raises Price Target on Intra-Cellular Therapies to $107 From $103, Keeps Outperform Rating

ITCI

Zacks

5 months ago

Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe

Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87

ITCI

Investor's Business Daily

5 months ago

Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87

ITCI

MT Newswires

5 months ago

Needham Adjusts Intra-Cellular Therapies Price Target to $94 From $90, Maintains Buy Rating

ITCI

MT Newswires

5 months ago

RBC Capital Adjusts Intra-Cellular Therapies Price Target to $103 From $96, Maintains Outperform Rating

ITCI

MT Newswires

5 months ago

Goldman Sachs Adjusts Intra-Cellular Therapies Price Target to $77 From $76, Maintains Neutral Rating

ITCI

MT Newswires

5 months ago

Mizuho Securities Adjusts Intra-Cellular Therapies Price Target to $100 From $96, Maintains Buy Rating

ITCI

MT Newswires

5 months ago

Canaccord Genuity Adjusts Intra-Cellular Therapies Price Target to $113 From $107, Maintains Buy Rating

ITCI

Zacks

5 months ago

Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News

ITCI

Zacks

5 months ago

Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals

ITCI

Zacks

5 months ago

Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?

Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression

ITCI

Clinical Trials Arena

5 months ago

Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression

Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win

ITCI

Investor's Business Daily

5 months ago

Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win

ITCI

MT Newswires

5 months ago

Intra-Cellular Therapies Says Depressive Disorder Therapy Meets Primary, Secondary Endpoints in Second Late-Stage Study

Intra-Cellular depression drug succeeds in second late-stage study

ITCI

BioPharma Dive

5 months ago

Intra-Cellular depression drug succeeds in second late-stage study

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

ITCI

GlobeNewswire

5 months ago

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

ITCI

GlobeNewswire

5 months ago

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

Italian energy company targets Britain for fleet of 20 mini-nukes

ITCI

The Telegraph

5 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

ITCI

Motley Fool

5 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

ITCI

AFP

5 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

ITCI

Simply Wall St.

5 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

ITCI

Simply Wall St.

5 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

ITCI

Simply Wall St.

5 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

ITCI

Simply Wall St.

5 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

ITCI

Motley Fool

5 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

ITCI

Zacks

5 months ago

Why Is Intra-Cellular (ITCI) Up 1.2% Since Last Earnings Report?

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

ITCI

GlobeNewswire

6 months ago

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

ITCI

Insider Monkey

6 months ago

Hedge Funds Like Intra-Cellular Therapies (NASDAQ:ITCI)

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

ITCI

GlobeNewswire

6 months ago

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

ITCI

Simply Wall St.

6 months ago

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think

ITCI

Insider Monkey

6 months ago

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

ITCI

GlobeNewswire

6 months ago

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

ITCI

GuruFocus.com

6 months ago

Intra-Cellular Therapies Inc (ITCI) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...

ITCI

MT Newswires

6 months ago

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

ITCI

GuruFocus.com

6 months ago

Intra-Cellular Therapies Surpasses Q1 Revenue Estimates with Strong CAPLYTA Sales

ITCI

Zacks

6 months ago

Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates

ITCI

MT Newswires

6 months ago

Intra-Cellular Therapies' Q1 Net Loss Narrows, Net Total Revenue Rises

ITCI

Associated Press Finance

6 months ago

Intra-Cellular: Q1 Earnings Snapshot

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

ITCI

GlobeNewswire

6 months ago

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?

ITCI

Zacks

7 months ago

Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

ITCI

GlobeNewswire

7 months ago

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

ITCI

Zacks

7 months ago

Will Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

ITCI

GlobeNewswire

7 months ago

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

ITCI

Insider Monkey

7 months ago

10 Best Performing Biotech ETFs in 2024

Intra-Cellular Therapies Prices Public Offering of Common Stock

ITCI

GlobeNewswire

7 months ago

Intra-Cellular Therapies Prices Public Offering of Common Stock

Biotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point

ITCI

Investor's Business Daily

7 months ago

Biotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point

ITCI

Zacks

7 months ago

Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals

ITCI

Zacks

7 months ago

Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

ITCI

GlobeNewswire

7 months ago

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

Intra-Cellular Launches 23% To Record High, Breaking Out After Depression Drug Scores Big

ITCI

Investor's Business Daily

7 months ago

Latest Intra-Cellular Therapies Inc. (ITCI) News on November 21, 2024

Share on Social Networks: